Effect of low molecular weight heparin (LMWH) treatment on expression of TNF-α in rat models of nephrotic syndrome (NS)
Creators
- 1. Department of Nephrology, Affiliated Yijishan Hospital, Wannan Medical College, Wuhu (China)
Description
Objective: To investigate the effect of low molecular weight heparin (LMWH) treatment on TNF-α expression in rat models of nephrotic syndrome (NS). Methods: Fourty-eight rat models of nephrotic syndrome (proteinuria over 100 mg/d) were successfully prepared with i.v. adriamycin. After two weeks, half of the models (n=24) were treated with intrapenitoneal LMWH (200u/kg/d). Animals were sacrificed in the two groups of models at the end of 2nd, 3rd and 4th week. The 24h urinary protein, ser- tun albumin and TNF-α levels were measured in these animals. Results: In the nephrotic syndrome models, the serum TNF-α levels were significantly higher than those in the 18 control rats. The levels were positively correlated with the amount of 24h proteinuria (P<0.01). In the models treated with LMWH, the serum TNF-α levels decreased, 24h proteinuria decreased with increased serum albumin (vs the corresponding values in those models without LMWH treatment, P<0.05 or P<0.01). Conclusion: LMWH treat- merit could decrease the serum TNF-α levels in rat models of nephrotic syndrome, which might be one of the nephro-protective mechanisms of LMWH. (authors)
Additional details
Publishing Information
- Journal Title
- Journal of Radioimmunology
- Journal Volume
- 20
- Journal Issue
- 4
- Journal Page Range
- p. 290-293
- ISSN
- 1008-9810
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 41043309
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ABSORPTION SPECTROSCOPY; ALBUMINS; BLOOD SERUM; DIAGNOSIS; DOXORUBICIN; HEPARIN; KIDNEYS; MOLECULAR WEIGHT; PATHOGENESIS; PROTEINS; RADIOIMMUNOASSAY; RATS; RESPONSE MODIFYING FACTORS; URINE; UROGENITAL SYSTEM DISEASES
- Descriptors DEC
- AMINES; ANIMALS; ANTIBIOTICS; ANTICOAGULANTS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC DRUGS; BIOASSAY; BIOLOGICAL MATERIALS; BIOLOGICAL WASTES; BLOOD; BLOOD PLASMA; BODY; BODY FLUIDS; CARBOHYDRATES; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; HEMATOLOGIC AGENTS; IMMUNOASSAY; ISOTOPE APPLICATIONS; MAMMALS; MATERIALS; MUCOPOLYSACCHARIDES; ORGANIC COMPOUNDS; ORGANIC SULFUR COMPOUNDS; ORGANS; POLYSACCHARIDES; PROTEINS; RADIOASSAY; RADIOIMMUNODETECTION; RODENTS; SACCHARIDES; SPECTROSCOPY; TRACER TECHNIQUES; VERTEBRATES; WASTES
Optional Information
- Notes
- 1 fig., 1 tab., 12 refs.